Arrowstreet Capital’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-24,188
| Closed | -$574K | – | 1599 |
|
|
2023
Q3 | $574K | Sell |
24,188
-105,970
| -81% | -$1.99M | ﹤0.01% | 1084 |
|
|
2023
Q2 | $2.11M | Sell |
130,158
-34,682
| -21% | -$575K | ﹤0.01% | 814 |
|
|
2023
Q1 | $2.87M | Sell |
164,840
-72,812
| -31% | -$1.31M | ﹤0.01% | 829 |
|
|
2022
Q4 | $4.46M | Buy |
237,652
+189,021
| +389% | +$3.64M | 0.01% | 703 |
|
|
2022
Q3 | $861K | Sell |
48,631
-41,356
| -46% | -$718K | ﹤0.01% | 1011 |
|
|
2022
Q2 | $1.57M | Buy |
89,987
+76,095
| +548% | +$1.45M | ﹤0.01% | 835 |
|
|
2022
Q1 | $290K | Sell |
13,892
-299,398
| -96% | -$5.73M | ﹤0.01% | 1079 |
|
|
2021
Q4 | $5.57M | Sell |
313,290
-115,874
| -27% | -$1.86M | 0.01% | 795 |
|
|
2021
Q3 | $6.05M | Sell |
429,164
-18,259
| -4% | -$284K | 0.01% | 886 |
|
|
2021
Q2 | $7.42M | Buy |
447,423
+42,676
| +11% | +$765K | 0.01% | 935 |
|
|
2021
Q1 | $7.33M | Sell |
404,747
-38,856
| -9% | -$767K | 0.01% | 1003 |
|
|
2020
Q4 | $8.09M | Buy |
443,603
+7,390
| +2% | +$117K | 0.01% | 971 |
|
|
2020
Q3 | $5.56M | Buy |
436,213
+21,008
| +5% | +$268K | 0.01% | 1101 |
|
|
2020
Q2 | $4.56M | Sell |
415,205
-17,056
| -4% | -$177K | 0.01% | 1099 |
|
|
2020
Q1 | $4.51M | Sell |
432,261
-14,561
| -3% | -$188K | 0.01% | 772 |
|
|
2019
Q4 | $7.18M | Buy |
446,822
+142,031
| +47% | +$2.35M | 0.02% | 743 |
|
|
2019
Q3 | $4.78M | Sell |
304,791
-207,280
| -40% | -$3.45M | 0.01% | 720 |
|
|
2019
Q2 | $10.2M | Buy |
512,071
+13,800
| +3% | +$258K | 0.02% | 480 |
|
|
2019
Q1 | $8.39M | Buy |
498,271
+182,836
| +58% | +$3.17M | 0.02% | 609 |
|
|
2018
Q4 | $4.78M | Sell |
315,435
-9,501
| -3% | -$163K | 0.01% | 586 |
|
|
2018
Q3 | $6.53M | Buy |
324,936
+244,788
| +305% | +$5.19M | 0.01% | 474 |
|
|
2018
Q2 | $1.56M | Buy |
+80,148
| New | +$1.27M | ﹤0.01% | 728 |
|
|
2018
Q1 | – | Sell |
-99,774
| Closed | -$1.35M | – | 1396 |
|
|
2017
Q4 | $1.35M | Sell |
99,774
-65,550
| -40% | -$941K | ﹤0.01% | 908 |
|
|
2017
Q3 | $2.6M | Buy |
165,324
+109,116
| +194% | +$1.76M | 0.01% | 637 |
|
|
2017
Q2 | $967K | Buy |
+56,208
| New | +$854K | ﹤0.01% | 786 |
|
|
2016
Q4 | – | Sell |
-183,101
| Closed | -$2.07M | – | 2635 |
|
|
2016
Q3 | $2.07M | Sell |
183,101
-236,225
| -56% | -$2.84M | 0.01% | 922 |
|
|
2016
Q2 | $4.99M | Buy |
419,326
+195,547
| +87% | +$2.63M | 0.02% | 588 |
|
|
2016
Q1 | $3.41M | Buy |
223,779
+642
| +0.3% | +$9.74K | 0.01% | 647 |
|
|
2015
Q4 | $3.6M | Buy |
223,137
+45,463
| +26% | +$664K | 0.02% | 633 |
|
|
2015
Q3 | $2.22M | Sell |
177,674
-125,878
| -41% | -$1.73M | 0.01% | 726 |
|
|
2015
Q2 | $5.03M | Buy |
303,552
+146,500
| +93% | +$2.36M | 0.03% | 427 |
|
|
2015
Q1 | $2.51M | Sell |
157,052
-12,270
| -7% | -$203K | 0.02% | 560 |
|
|
2014
Q4 | $2.64M | Buy |
169,322
+30,065
| +22% | +$439K | 0.02% | 645 |
|
|
2014
Q3 | $1.92M | Buy |
+139,257
| New | +$2.11M | 0.01% | 599 |
|
|
2014
Q2 | – | Sell |
-129,203
| Closed | -$2.18M | – | 1222 |
|
|
2014
Q1 | $2.18M | Buy |
+129,203
| New | +$2.34M | 0.01% | 636 |
|
|
2013
Q4 | – | Sell |
-134,482
| Closed | -$2.92M | – | 1321 |
|
|
2013
Q3 | $2.92M | Buy |
134,482
+92,107
| +217% | +$1.97M | 0.02% | 478 |
|
|
2013
Q2 | $793K | Buy |
+42,375
| New | +$773K | 0.01% | 568 |
|
Other funds holding NXGN
Arrowstreet Capital's NXGN Position: Q4 2023 in Review
Arrowstreet Capital sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 24,188 shares — an estimated $574K sold.
Arrowstreet Capital first reported a position in NXGN in Q2 2013 and held it in 37 quarters. The position peaked at $10.2M in Q2 2019. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Arrowstreet Capital reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Arrowstreet Capital sold 24,188 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $574K.
- Arrowstreet Capital first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 37 quarters.
- Arrowstreet Capital's NextGen Healthcare, Inc. Common Stock position peaked at $10.2M in Q2 2019.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Arrowstreet Capital's 13F filing for Q4 2023, filed 14 Feb 2024.